Skip to main content

Vitiligo In Adults And Adolescents

Let’s break the stigma of Vitiligo together. Help us discover potential treatments for Vitiligo by enrolling in our HIPAA-compliant clinical trials.

Let’s Overcome

Vitiligo

Vitiligo causes white patches or depigmentation of the skin; it is the most common form of vitiligo. It affects around 0.5% – 2% of the population globally. Vitiligo can occur at any age and affects people of all races and ethnicities. Currently limited treatment options include topical steroids, vitamin D3, calcineurin inhibitors, topical immunomodulators, phototherapy, surgical treatments, and camouflage. MetroBoston is conducting clinical trials in vitiligo to determine the safety and efficacy of new potential treatments that may improve skin pigmentation.

form will be displayed here

Safety, efficacy, and Tolerability Evaluation

Eligibility Criteria

Enroll in our Vitiligo clinical trial and help us untether the complications of Vitiligo.

Age

10-19 Years & Above

Gender

Male and Female

Current Status

Recruiting

Total Studies

01

Location

Brighton – Boston